SCHEMBL8880188

SCHEMBL8880188

CCC(C)CCC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.41
KCNH2 Q12809 3/20 0.41
GRIN2D O15399 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
DRD3 P35462 2/20 0.41
CACNA1F O60840 1/20 0.41
ABCB1 P08183 1/20 0.41
CYP2B6 P20813 1/20 0.41
DRD4 P21917 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
CACNA1D Q01668 1/20 0.41
CACNA1S Q13698 1/20 0.41
CACNA1C Q13936 1/20 0.41
MRGPRX2 Q96LB1 1/20 0.41
KCNN4 O15554 1/20 0.41
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8939163 0.84 KCNN4 (0.44) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL7826479 0.76 HDAC11 (0.41) CYP2D6CYP1A2
SCHEMBL13828216 0.74 OPRM1 (0.55) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL15661338 0.74 L3MBTL1 (0.52) KMT2ALMNACYP2C19HIF1AKDM4E
SCHEMBL8939190 0.73 KCNN4 (0.44) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL7826487 0.73 KCNN4 (0.42) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL8939167 0.73 KCNN4 (0.47) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL3999317 0.72 CYP2D6 (0.41) OPRM1KCNH2GRIN2DGRIN1GRIN2A
SCHEMBL668103 0.70 ELANE (0.45) KMT2ACYP1A2LMNAHIF1AKDM4E
SCHEMBL8939182 0.70 KCNN4 (0.44) OPRM1KCNH2GRIN2DGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665716-A 24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom SCHERING AKTIENGESELLSCHAFT (DE) 1997-09-09 US disclosed